Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASTRO 2022 | Potential of de-escalating systemic cancer therapies in GU cancers

Chad Tang • 27 Oct 2022
ASTRO 2022

Chad Tang, MD, University of Texas MD Anderson Cancer Center, Houston, TX discusses the future potential of de-escalating systemic therapies for patients with genitourinary cancers. This interview took place at the American Society for Radiation Oncology (ASTRO) 2022 Congress in San Antonio, Tx.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Chad Tang

KIM-1 and ctDNA as prognostic markers in oligometastatic ccRCC
0:48
KIM-1 and ctDNA as prognostic markers in oligometastatic ccRCC
Chad Tang • 28 Feb 2026
The role of PSMA PET in metastatic prostate cancer staging
0:37
The role of PSMA PET in metastatic prostate cancer staging
Chad Tang • 14 Feb 2025
Managing oligoprogressive kidney cancer with radiation therapy
0:53
Managing oligoprogressive kidney cancer with radiation therapy
Chad Tang • 14 Feb 2025
Evaluating metastasis-directed therapy in oligometastatic prostate cancer
0:47
Evaluating metastasis-directed therapy in oligometastatic prostate cancer
Chad Tang • 14 Feb 2025

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals